At Neuronostics we are unlocking the wealth of information contained within the electrical activity of the brain to support advanced diagnosis and management of neurological conditions.
Our first clinical indication #BioEP is a patented seizure risk score for use in epilepsy diagnosis and prognosis.
Timeline
———
2021 TechSpark’s Most Innovative Use of Tech Award
2020 Neuronostics – Medilink SW Start-up of the year
2018 Innovate UK Health & Life-Science Award (£349K)
2017 #BioEP – Epilepsy Foundation Commercialisation Prize ($5K)
Company’s Keywords:
epilepsy, medical diagnostics, healthcare technologies, computational neuroscience, mathematics, technology, software as a service
<7
<3000000
<2018